Whether your company is a start-up or well established, taking a new biological product or cellular therapy from laboratory to market requires a scalable process. Terumo BCT's cell culture technology offers the scalability and automation these go-to-market projects demand.

Addressing this need early—establishing a scalable and efficient process in the pre-clinical stage of development—protects the

commercial viability of your projects. What's

more, adopting scalable processes early

may eliminate the need to revalidate or

revisit your manufacturing processes later.

Terumo BCT also delivers technologies for secondary cell processing and dependable tools for maintaining sterility—solutions that support you in developing cell therapies that may fundamentally improve

health care.